SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Phase III awaiting (ie completed phase II, not yet in III)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: QuietWon who wrote (9)1/31/1999 3:21:00 PM
From: QuietWon  Read Replies (1) of 32
 
just to clarify the "50% rise" on SCIO, that's 50% of its longer term rise, not 50% of the price it's at. What we don;t know is where the price will be, say 6-12 months AFTER Mktg approval stage. Say, it's 40 at that point. Then 50%of the rise will occur between now and the MArketing approval. The rise being 40-10 =30 x 50% = 15, so we could see $25 at Marketing approval point.

Of course it could go over $25 at any point between now & mktg approval. And of course that's a statistical average for biotechs. It could go less or more.

Hope it's not too confusing, that's the way the article read from my rem.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News